Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era

Published: 09/11/2024

1 day ago – The benefit of high-dose melphalan followed by autologous hematopoietic
stem cell transplantation (HDM-ASCT) for multiple myeloma (MM) patients with renal …